{"id":23902,"date":"2022-07-21T11:10:10","date_gmt":"2022-07-21T14:10:10","guid":{"rendered":"https:\/\/femama.org.br\/site\/?p=23902"},"modified":"2022-07-21T11:10:10","modified_gmt":"2022-07-21T14:10:10","slug":"olaparibe-ans-chamamento-publico-femama","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/","title":{"rendered":"Olaparibe entra em discuss\u00e3o"},"content":{"rendered":"<p><span style=\"color: #000000;\">No Brasil, anualmente, s\u00e3o registrados cerca de 6,5 mil casos novos de c\u00e2ncer de ov\u00e1rio, de acordo com o INCA \u2013 Instituto Nacional do C\u00e2ncer. Trata-se de uma doen\u00e7a silenciosa e o risco de desenvolv\u00ea-la aumenta com a idade. Raramente \u00e9 diagnosticado em mulheres com menos de 40 anos. As mulheres mais afetadas s\u00e3o aquelas que j\u00e1 passaram pela menopausa.<\/span><\/p>\n<p><span style=\"color: #000000;\">A causa da maioria dos casos de c\u00e2ncer de ov\u00e1rio ainda \u00e9 desconhecida. O que se sabe \u00e9 que alguns fatores de risco tornam a mulher mais propensa a desenvolver a doen\u00e7a, como idade e hist\u00f3rico familiar, por exemplo. 25% dos casos s\u00e3o heredit\u00e1rios.<\/span><br \/>\n<span style=\"color: #000000;\">Os inibidores de PARP (grupo de inibidores farmacol\u00f3gicos da enzima Poli Adenosina difosfato Ribose|Polimerase), que funcionam como uma quimioterapia oral e s\u00e3o utilizados para tratamento de pacientes que possuem uma muta\u00e7\u00e3o nos genes BRCA1 e BRCA2 incluem o Olaparibe, sendo importantes tecnologias j\u00e1 utilizadas em outros pa\u00edses, com efeitos cient\u00edficos comprovados e efetivos no tratamento de pacientes com c\u00e2ncer de ov\u00e1rio. O reconhecimento dos efeitos cl\u00ednicos d\u00e1-se inclusive por Sociedades M\u00e9dicas Internacionais.<\/span><\/p>\n<p><span style=\"color: #000000;\">Frente a este cen\u00e1rio, a FEMAMA mobiliza a sociedade com a Campanha D\u00ea Mais Aten\u00e7\u00e3o, voltada \u00e0 ANS (Ag\u00eancia Nacional da Sa\u00fade Suplementar) para avalia\u00e7\u00e3o e incorpora\u00e7\u00e3o aos planos de sa\u00fade o Olaparibe. A submiss\u00e3o do mesmo medicamento fez-se para duas indica\u00e7\u00f5es distintas. Ambas as recomenda\u00e7\u00f5es possuem parecer FAVOR\u00c1VEL \u00c0 INCORPORA\u00c7\u00c3O pela Ag\u00eancia.<\/span><\/p>\n<p><span style=\"color: #000000;\">Conhe\u00e7a as indica\u00e7\u00f5es:<\/span><br \/>\n<span style=\"color: #000000;\"><strong>UAT 32 \u2013 OLAPARIBE<\/strong>\u00a0&#8211; Tratamento de manuten\u00e7\u00e3o para pacientes com carcinoma de ov\u00e1rio seroso de alto grau, com muta\u00e7\u00e3o BRCA 1 e\/ou 2, recidivado e sens\u00edvel \u00e0 platina.<\/span><br \/>\n<span style=\"color: #000000;\">A indica\u00e7\u00e3o \u00e9 para tratamento de manuten\u00e7\u00e3o de pacientes adultas comcarcinoma de ov\u00e1rio seroso (incluindo trompa de Fal\u00f3pio ou peritoneal prim\u00e1rio) ou endometrioide, de alto grau (grau 2 ou maior), recidivado, sens\u00edvel \u00e0 platina e que respondem (resposta completa ou parcial) \u00e0 quimioterapia baseada em platina.<\/span><\/p>\n<p><span style=\"color: #000000;\"><strong>UAT 33 \u2013 OLAPARIBE<\/strong>\u00a0&#8211; Tratamento de manuten\u00e7\u00e3o para pacientes com carcinoma de ov\u00e1rio, recentemente diagnosticado, de alto grau, avan\u00e7ado, com muta\u00e7\u00e3o BRCA e resposta \u00e0 quimioterapia de primeira linha, baseada em platina.<\/span><br \/>\n<span style=\"color: #000000;\">Neste caso a indica\u00e7\u00e3o \u00e9 para terapia de manuten\u00e7\u00e3o para pacientes adultas com carcinoma de ov\u00e1rio (incluindo trompa de Fal\u00f3pio ou peritoneal prim\u00e1rio), recentemente diagnosticado, de alto grau (2 ou maior), avan\u00e7ado, com muta\u00e7\u00e3o BRCA, que respondem (resposta completa ou parcial) \u00e0 quimioterapia em primeira linha, baseada em platina.<\/span><\/p>\n<h3><span style=\"color: #000000;\"><strong>Sobre a Campanha<\/strong><\/span><\/h3>\n<p><span style=\"color: #000000;\">Nos \u00faltimos anos o avan\u00e7o da medicina trouxe mais qualidade de vida, melhores progn\u00f3sticos, novos tratamentos e um novo olhar personalizado para o c\u00e2ncer de mama. Com o prop\u00f3sito de atuar durante toda a jornada da paciente com a doen\u00e7a, a FEMAMA tamb\u00e9m luta por acesso a tratamento tanto na esfera p\u00fablica quanto na privada.<\/span><\/p>\n<p><span style=\"color: #000000;\">O site\u00a0<strong>D\u00ea Mais Aten\u00e7\u00e3o #ELAPRECISA<\/strong>\u00a0\u00e9 um espa\u00e7o pensado e criado para sensibilizar a sociedade, inform\u00e1-la das consultas p\u00fablicas em andamento e contribuir para suas incorpora\u00e7\u00f5es. Atrav\u00e9s do portal mobilizamos a #RedeFEMAMA, parceiros e p\u00fablico em geral com consultas p\u00fablicas. A FEMAMA seguir\u00e1 sempre a favor dos pacientes e ONGs que os assistem, mobilizando agentes de sa\u00fade e governo para que permitam o acesso de novas tecnologias a todos.<\/span><\/p>\n<p><span style=\"color: #000000;\">Engaje-se em<\/span> <a href=\"https:\/\/demaisatencao.femama.org.br\/\">https:\/\/demaisatencao.femama.org.br\/<\/a><\/p>\n<p><span style=\"color: #000000;\">Cr\u00e9dito da imagem: Polina Tankilevitch\/Pexels<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Campanha D\u00ea Mais Aten\u00e7\u00e3o \u00e9 a favor de duas indica\u00e7\u00f5es para o medicamento<\/p>\n","protected":false},"author":7,"featured_media":23903,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-23902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-recentes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Olaparibe entra em discuss\u00e3o | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Olaparibe entra em discuss\u00e3o | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"Campanha D\u00ea Mais Aten\u00e7\u00e3o \u00e9 a favor de duas indica\u00e7\u00f5es para o medicamento\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T14:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2022\/07\/foto-materia-olaparibe-chamamento-publico-2022-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Femama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Femama\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/\"},\"author\":{\"name\":\"Femama\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\"},\"headline\":\"Olaparibe entra em discuss\u00e3o\",\"datePublished\":\"2022-07-21T14:10:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/\"},\"wordCount\":588,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/foto-materia-olaparibe-chamamento-publico-2022.png\",\"articleSection\":[\"Not\u00edcias recentes\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/\",\"name\":\"Olaparibe entra em discuss\u00e3o | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/foto-materia-olaparibe-chamamento-publico-2022.png\",\"datePublished\":\"2022-07-21T14:10:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#primaryimage\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/foto-materia-olaparibe-chamamento-publico-2022.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/foto-materia-olaparibe-chamamento-publico-2022.png\",\"width\":3712,\"height\":2475},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/olaparibe-ans-chamamento-publico-femama\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Olaparibe entra em discuss\u00e3o\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\",\"name\":\"Femama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"caption\":\"Femama\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Olaparibe entra em discuss\u00e3o | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/","og_locale":"pt_BR","og_type":"article","og_title":"Olaparibe entra em discuss\u00e3o | FEMAMA","og_description":"Campanha D\u00ea Mais Aten\u00e7\u00e3o \u00e9 a favor de duas indica\u00e7\u00f5es para o medicamento","og_url":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2022-07-21T14:10:10+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2022\/07\/foto-materia-olaparibe-chamamento-publico-2022-1024x683.png","type":"image\/png"}],"author":"Femama","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"Femama","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/"},"author":{"name":"Femama","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e"},"headline":"Olaparibe entra em discuss\u00e3o","datePublished":"2022-07-21T14:10:10+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/"},"wordCount":588,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2022\/07\/foto-materia-olaparibe-chamamento-publico-2022.png","articleSection":["Not\u00edcias recentes"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/","url":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/","name":"Olaparibe entra em discuss\u00e3o | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#primaryimage"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2022\/07\/foto-materia-olaparibe-chamamento-publico-2022.png","datePublished":"2022-07-21T14:10:10+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#primaryimage","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2022\/07\/foto-materia-olaparibe-chamamento-publico-2022.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2022\/07\/foto-materia-olaparibe-chamamento-publico-2022.png","width":3712,"height":2475},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/olaparibe-ans-chamamento-publico-femama\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Olaparibe entra em discuss\u00e3o"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e","name":"Femama","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","caption":"Femama"}}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/23902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=23902"}],"version-history":[{"count":3,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/23902\/revisions"}],"predecessor-version":[{"id":23906,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/23902\/revisions\/23906"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media\/23903"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=23902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=23902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=23902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}